| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Chardonnet Laurent is a Chief Financial Officer at Prelude Therapeutics Inc. Recent SEC Form 4 filings include 3 buys and 0 sells.
Estimated insider holdings value: $182K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 23, 2023 | PRLD Prelude Therapeutics Inc | Chief Financial Officer | Buy | 5,000 | $5.50 | $27,500.00 | +13.5% | -38.7% | -24.4% | |
| Dec 8, 2022 | PRLD Prelude Therapeutics Inc | Chief Financial Officer | Buy | 10,000 | $4.76 | $47,600.00 | +38.7% | +19.2% | -33.6% | |
| Jun 1, 2022 | PRLD Prelude Therapeutics Inc | Chief Financial Officer | Buy | 10,000 | $4.23 | $42,300.00 | +69.0% | +69.1% | +32.1% |